Bevacizumab - BEVAZZA

Bevazza (Bevacizumab) is available in a single dose vial with two strengths, 100 mg and 400 mg.

Bevazza (Bevacizumab) biosimilar of Avastin is manufactured by Lupin

Bevazza (Bevacizumab) biosimilar of Avastin, is medication used to treat a number of types of cancers and a specific eye disease. For cancer Bevazza (Bevacizumab) is given by slow injection into a vein and used for colon cancer, lung cancer, glioblastoma, and renal-cell carcinoma. For age-related macular degeneration Bevazza (Bevacizumab) is given by injection into the eye. It works by blocking a certain protein (vascular endothelial growth factor-VEGF) thereby decreasing the blood supply to the tumor and slowing tumor growth.

Bevazza (Bevacizumab) is manufactured by Lupin in India and is a biosimilar of Avastin